Name and surname:
|
Mgr. Veronika Holubeková, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Researcher - postdoc | Jessenius faculty of medicine CU in Martin | 2013 - 2015 |
Researcher | Jessenius faculty of medicine CU in Martin | 2017 - 2021 |
Researcher class IIa | Jessenius faculty of medicine CU in Martin | 2021 - current |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
Professional training for working with highly toxic substances and mixtures and toxic substances and mixtures, Axelum, s.r.o. | Axelum, sro | 2022 |
Fiolka, Roman, Žúbor, Pavol, Holubeková, Veronika, Višňovský, Jozef, Hornáková, Andrea, Kajo, Karol, Lasabová, Zora, Plank, Lukáš, Danko, Ján. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncology Reports, 2013, roč. 30, č. 6 (2013), s. 2878-2886.
Holubeková, Veronika, Hornáková, Andrea, Grendár, Marián, Meršaková, Sandra, Chmúrna, Ivana, Jašek, Karin, Vaňochová, Andrea, Danko, Ján, Lasabová, Zora. Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens. Oncology Letters, 2016, roč. 12, č. 4, s. 2613-2621.
Holubeková, Veronika, Hornáková, Andrea, Jašek, Karin, Meršaková, Sandra, Žúbor, Pavol, Lasabová, Zora. Epigenetic regulation by DNA methylation and miRNA molecules in cancer. Future Oncology, 2017, roč. 13, č. 25, s. 2217-2222.
Meršaková, Sandra, Holubeková, Veronika, Grendár, Marián, Višňovský, Jozef, Ňachajová, Marcela, Kalman, Michal, Kúdela, Erik, Žúbor, Pavol, Bielik, Tibor, Lasabová, Zora, Danko, Ján. Methylation of CADM1 and MAL together with HPVstatus in cytological cervical specimens serves an important role in the progression of cervical intraepithelial neoplasia. Oncology Letters, 2018, roč. 16, č. 6, s. 7166-7174.
Holubeková, Veronika, Kolková, Zuzana, Grendár, Marián, Braný, Dušan, Dvorská, Dana, Šťastný, Igor, Jagelková, Marianna, Zelinová, Katarína, Samec, Marek, Mazuráková, Alena, Ondák Laučeková, Zuzana, Kúdela, Erik, Bobrovská, Martina, Kalman, Michal, Žúbor, Pavol, Danková, Zuzana. Pathway analysis of selected circulating mirnas in plasma of breast cancer patients: A preliminary study. International journal of molecular sciences , 2020, Roč. 21, č. 19, s. [1-16], no. 7288.
Holubeková, Veronika, Meršaková, Sandra, Grendár, Marián, Kolková, Zuzana, Kúdela, Erik, Kalman, Michal, Lasabová, Zora, Danko, Ján, Žúbor, Pavol. The Role of CADM1 and MAL Promoter Methylation in Inflammation and Cervical Intraepithelial Neoplasia. Genetic Testing and Molecular Biomarkers, 2020, roč. 24, č. 5, s. 256-263.
Kolková, Zuzana, Holubeková, Veronika, Grendár, Marián, Ňachajová, Marcela, Žúbor, Pavol, Pribulová, Terézia, Loderer, Dušan, Žigo, Imrich, Biringer, Kamil, Hornáková, Andrea. Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity. Diagnostics, 2021, roč. 11, č. 3, s. [1-15].
Kúdelová, Eva, Holubeková, Veronika, Grendár, Marián, Kolková, Zuzana, Samec, Marek, Váňová, Barbora, Mikolajčík, Peter, Smolár, Marek, Kúdela, Erik, Laca, Ľudovít, Lasabová, Zora. Circulating miRNA expression over the course of colorectal cancer treatment. Oncology Letters, 2022, roč. 23, č. 1 (2022), s. [1-15], no. 18.
Rokos, Tomáš, Holubeková, Veronika, Kolková, Zuzana, Hornáková, Andrea, Pribulová, Terézia, Kozubík, Erik, Biringer, Kamil, Kúdela, Erik. Is the Physiological Composition of the Vaginal Microbiome Altered in High-Risk HPV Infection of the Uterine Cervix? Viruses, 2022, roč. 14, č. 10, s. [1-10], no. 2130.
Holubeková, Veronika, Loderer, Dušan, Grendár, Marián, Mikolajčík, Peter, Kolková, Zuzana, Túryová, Eva, Kúdelová, Eva, Kalman, Michal, Marcinek, Juraj, Miklušica, Juraj, Laca, Ľudovít, Lasabová, Zora. Differential gene expression of immunity and inflammation genes in colorectal cancer using targeted RNA sequencing. Frontiers in oncology, 2023, roč. 13, č. Október (2023), s. [1-17].
09I03-03-V04-00228, Epigenetic changes in the development of cervical cancer, Main researcher: Mgr. Veronika Holubeková, PhD. (Call: Scholarships for excellent R2-R4 researchers)
APVV-23-0428: The role of the vaginal microbiome and immune system in the process of HPV-induced cervical carcinogenesis. Main researcher: Prof. MUDr. Erik Kúdela, PhD.
ITMS 313011AUA4: New possibilities of laboratory diagnostics and massive screening SARS-COV-2 and identifying the mechanisms of virus behavior in the human body. Operational program Integrated infrastructure. COVLAB.
ITMS: 313011AFG5: Systemic public research infrastructure - biobank for cancer and rare diseases. Operational program Integrated Infrastructure 2014-2020. Bioford.
ITMS 313011V446: Integrative strategy in the development of personalized medicine of selected malignant cancer and its impact on the quality of life. Operational program Integrated Infrastructure 2014-2020. Lisper.
VEGA 1/0269/22, "Study of differential gene expression of immunity genes, inflammation and hypoxia in colorectal cancer." Main researcher: doc. RNDr. Zora Lasabova, PhD.
VEGA 1/0398/21, “The immune system and vaginal microbiome as important mediators in the process of cervical carcinogenesis”, Main researcher: doc. MUDr. Erik Kúdela, PhD.
VEGA 1/0380/18: Analyzes of methylated DNA sequences in plasma as an universal marker of colorectal carcinoma relapse. Main researcher: doc. RNDr. Zora Lasabova, PhD.